Evaluation of Quality of Life (QoL) in Subjects With Highly Active Relapsing Multiple Sclerosis (MS) (CLARIFY MS)

PHASE4CompletedINTERVENTIONAL
Enrollment

485

Participants

Timeline

Start Date

June 20, 2018

Primary Completion Date

November 12, 2021

Study Completion Date

November 12, 2021

Conditions
Multiple Sclerosis
Interventions
DRUG

Mavenclad®

Participants with Relapsing Multiple Sclerosis (RMS) received Mavenclad® 3.5 milligram per kilogram (mg/kg) of body weight over 2 years, administered as 1 treatment course of 1.75 mg/kg per year. Each treatment course consisted of 2 treatment weeks, one at the beginning of the first month and one at the beginning of the second month of the respective year.

Trial Locations (92)

290

Helsinki University Central Hospital, Helsinki

1083

Semmelweis Egyetem AOK, Budapest

1145

Uzsoki Utcai Korhaz, Budapest

1200

Cliniques Univ. St.-Luc, Brussels

1204

Jahn Ferenc Dél-Pesti Kórház és Rendelőintézet, Budapest

1340

Clinique Saint Pierre, Ottignies

2500

VALEOMED Kft, Esztergom

2650

UZ Antwerpen, Edegem

3004

Drammen Hospital, Drammen

4021

Kepler Universitätsklinikum, Linz

4032

University of Debrecen, Debrecen

4403

Szabolcs-Szatmár-Bereg Megyei Kórházak és Egyetemi Oktatókór, Nyíregyháza

6400

Matthias Kant, Sønderborg

8661

Vilnius University Hospital Santariskiu Clinics, Vilnius

9100

Aalborg Hospital, Aalborg

11526

Hos. Errikos Dynan, Athens

11527

401 Army Hospital, Athens

Athens Medical Centre, Athens

14033

University Hospital of Caen, Caen

15706

Complejo Hospitalario Universitario de Santiago, Santiago de Compostela

20127

Ospedale San Raffaele, IRCCS, Milan

20133

"Instituto Nazionale Neurologico Carlo Besta", Milan

24071

C.A.U. de León - H. de León, León

25198

Hospital Arnau de Vilanova, Lleida

28007

Hospital General Universitario Gregorio Marañón (5030), Madrid

28040

H. U. Quirónsalud Madrid, Madrid

28905

Hospital Universitario de Getafe, Madrid

30120

Hospital Virgen de la Arrixaca, Murcia

31059

Hopital Pierre-Paul Riquet - Neurologie, Toulouse

33076

Hopital Pellegrin, Bordeaux

37044

CHU Tours - Hôpital Bretonneau, Tours

38010

Hospital Universitario Nuestra Senora de la Candelaria (4776), Santa Cruz de Tenerfie

41013

Hospital Universitario Virgen del Rocio - Servicio de Oncologia, Seville

44093

CHU de Nantes, Nantes

50100

Terveystalo Mikkeli, Mikkeli

50161

Hospital of Lithuanian University of Health Sciences Kaunas, Kaunas

Klaipedos Ligonine, Kaunas

56501

FN Hradec Kralove, Choceň

59037

CHRU de Lille, Lille

59185

Motala Hospital (11119), Motala

63003

CHU Hopital Gabriel Montpied, Puy-de-Dome

64100

Centre hospitalier de la Côte Basque - Saint Léon, Bayonne

65691

FN u sv. Anny Brno, Brno

70852

Fakultni nemocnice Ostrava (11573), Ostrava

75013

Centre Hospitalier de Gonesse, Paris

Hôpital de la Pitié-Salpétrière, Paris

76031

Centre Universitaire de Rouen, Rouen

78303

CHU de Poissy, Poissy

80131

A.O. Universitaria Federico II, Napoli

90015

Ospedale San Raffaele Giglio, Cefalù

90146

Villa Sofia Hospital, Palermo

95125

Policlinico di Catania, Catania

Unknown

Paracelsus Medical University Salzburg, Salzburg

Eva Maida, Vienna

Odense Univeristy Hospital, Odense

Helsinki University Central Hospital, Helsinki

Neo Research, Neuro NEO Oy, Turku

Groupe Hospitalier de l'Institut Catholique de Lille - Centre Hospitalier Saint Philibert, Lomme

A.O.U. Ospedali Riuniti Umberto I, Ancona

Seconda Univesità degli Studi di Napoli, AOU, Napoli

Policlinico Tor Vergata, Roma

Institute of Neurological Sciences, Glasgow

586 33

Nemocnice Jihlava, p.o., Jihlava

779 00

Fakultni nemocnice Olomouc, Olomouc

100 34

Faculty Hospital Kralovske Vinohrad, Prague

128 08

Vseobecna fakultni nemocnice v Praze (11163), Prague

415 29

Nemocnice Teplice, Teplice

DK-2600

Glostrup University Hospital, Glostrup Municipality

09126

Ospedale Binaghi, Università di Cagliari,ASL 8 - Centro Sclerosi Multipla, Cagliari

00152

Azienda Ospedaliera S. Camillo Forlanini (8025), Roma

00189

Azienda Ospedaliera Sant'Andrea Università La Sapienza, Roma

Neurological Center Of Latium, Roma

6131 BG

Zuyderland, Sittard-Geleen

80-803

COPERNICUS Podmiot Leczn. Sp z o.o., Gdansk

40-571

M.A. - LEK A.M.Maciejowscy SC., Katowice

90-153

Centrum Neurologii K. Selmaj, Lodz

Uniwersytecki Szpital Kliniczny nr 1 i.m. Norberta Barlickie, Lodz

20-954

Centrum Medyczne Medyk, Lublin

Indywidualna Praktyka Lekarska Prof. Konrad Rejdak, Lublin

02-957

Instytut Psychiatrii i Neurologii, Warsaw

4710-243

Hospital de Braga, Braga

4099-001

Centro Hospitalar do Porto E.P.E. Hospital de Santo António, Porto

813 69

Univerzitna nemocnica Bratislava, Bratislava

036 01

Univerzitna nemocnica Martin, Martin

950 01

Fakultna nemocnica Nitra, Nitra

917 75

Fakultna nemocnica Trnava, Trnava

08970

Hospital de Sant Joan Despí Moisès Broggi, Sant Joan Despí

651 86

Karlstad Hospital (8232), Karlstad

G51 4TF

Institute of Neurological Sciences, Glasgow

M13 9WL

GM LCRN - Great Manchester Local Clinical Research Network, Manchester

NE1 4LP

The Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne

SA6 6NL

Morriston Hospital (4232), Swansea West Glamorgan

All Listed Sponsors
lead

Merck KGaA, Darmstadt, Germany

INDUSTRY

NCT03369665 - Evaluation of Quality of Life (QoL) in Subjects With Highly Active Relapsing Multiple Sclerosis (MS) (CLARIFY MS) | Biotech Hunter | Biotech Hunter